Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

26,829 signal articles · 32 in last 24h · 129,122 total before filter · latest 1h ago
32last 24h
1293last 7d
203● bullish (7d)
131● bearish (7d)
206publishers
AllMacro289Earnings512M&A86Regulatory19Product12Analyst18
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Musk Is Speaking. He Has a Big Goal for Starlink.
Barrons.com25d agoneutral
Musk Is Speaking. He Has a Big Goal for Starlink.

Tesla and SpaceX CEO Elon Musk always has some big, aspirational goals for investors to digest. Musk started the conference call with comments about the importance of Starship, SpaceX's huge, fully reusable rocket in development. Starlink is SpaceX's space-based broadband product that Musk said could someday provide the majority of the world's internet access.

Bloomberg25d agoneutral
Lucid Plans Business ‘Reset’ to Save $1.4 Billion in Cash

(Bloomberg) -- Lucid Group Inc. is targeting $1.4 billion in cash savings this year as part of a “comprehensive operational reset,” an effort by new Chief Executive Officer Silvio Napoli to shore up the money-losing maker of electric vehicles.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallIran Weighs Allowing Europe to Clear Mines in Strait o

Pinterest (NYSE:PINS) Beats Q2 CY2026 Sales Expectations But Stock Drops
StockStory25d agoneutral
Pinterest (NYSE:PINS) Beats Q2 CY2026 Sales Expectations But Stock Drops

Social commerce platform Pinterest (NYSE: PINS) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 18.2% year on year to $1.18 billion. The company expects next quarter’s revenue to be around $1.2 billion, close to analysts’ estimates. Its non-GAAP profit of $0.43 per share was 20.4% above analysts’ consensus estimates.

Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales
StockStory25d agoneutral
Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales

Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.5% year on year to $10.05 billion. The company’s full-year revenue guidance of $38.8 billion at the midpoint came in 2.8% above analysts’ estimates. Its non-GAAP profit of $6.29 per share was 12% above analysts’ consensus estimates.

CVS’s Turnaround Faces Its Next Test
Barrons.com25d agoneutral
CVS’s Turnaround Faces Its Next Test

CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.